(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

PROCESSO PARA PREPARAR UM INTERMEDIÁRIO DE PREGABALINA

ArquivadaInvention PatentPCT · US2007012971

Application data

Number

PI0702897

Type

Invention Patent

Filing

05/31/2007

Publication

03/15/2011

PCT

US2007012971

Progress at the INPI

  1. Filing05/31/07
  2. Publication03/15/11
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 05/31/2007 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 11/16/2011. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

TEVA PHARMACEUTICAL INDUSTRIES LTDA

IL

See this company's full portfolio

Inventors

A. F. (pessoa física)

IL

L. H. (pessoa física)

IL

Technical data

IPC Classification

Priority claims

US

60/809,978 · 05/31/2006

US

60/831,591 · 07/17/2006

US

60/836,730 · 08/09/2006

US

60/860,360 · 11/20/2006

US

60/879,870 · 01/10/2007

US

60/919,201 · 03/20/2007

US

60/926,059 · 04/23/2007

Abstract

PROCESSO PARA PREPARAR UM INTERMEDIÁRIO DE PRECABALINA. Provê-se o uso de resolução enzimática para a preparação de intermediários de pregabalina, inclusive (3S)-ciano-ácido 5-metilhexanóico e sais do mesmo e R-(±)3-(carbamoilmetil)-ácido 5-metil-hexanóico e sais do mesmo.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

11/16/2011

RPI 2132

Arquivamento - Art. 33 da LPI

#11.1

08/30/2011

RPI 2121

Notificação de entrada na fase nacional - PCT

#1.3

03/15/2011

RPI 2097

6.7

Apresente novas folhas de reivindicações com as páginas corretamente numeradas (1/14 até 14/14). Apresente ainda mais uma via completa do pedido.

11/11/2008

RPI 1975

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.